NEU — Neuren Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$2.57bn
- AU$2.34bn
- AU$237.63m
- 91
- 55
- 78
- 84
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -0.879 | -0.725 | 0.819 | -1.23 | 0.081 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -11.7 | -8.08 | -9.97 | 3.6 | 185 |
Capital Expenditures | -0.012 | -0.006 | -0.01 | -0.019 | -0.04 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | — | — | -211 |
Purchase of Investments | |||||
Cash from Investing Activities | -0.012 | -0.006 | -0.01 | -0.019 | -211 |
Financing Cash Flow Items | 1.86 | -1.07 | -1.11 | -0.002 | -0.018 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 1.86 | 19.1 | 22.2 | -0.002 | 3.62 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -9.73 | 10.3 | 12.6 | 3.4 | -23.1 |